Helping insomnia patients with a novel treatment that has no significant side effects or dependency is exciting to patients and the sleep clinical community
WOBURN, Mass. (PRWEB) October 17, 2017
Ebb Therapeutics, the medical device innovator of Ebb Insomnia Therapy, has selected The Copley Consulting Group to facilitate and deploy Infor’s CloudSuite Industrial (SyteLine) solution. With the first and only FDA-cleared device that reduces the time it takes insomnia patients to fall asleep and enter deeper sleep, Ebb is anticipating significant growth as it prepares for market launch.
“Helping insomnia patients with a novel treatment that has no significant side effects or dependency is exciting to patients and the sleep clinical community,” stated Don Spence, Ebb’s President and Chief Executive Officer. “With CloudSuite Industrial and the help of The Copley Consulting Group, we will be well positioned to grow Ebb Therapeutics by supplying our drug-free, efficacious solution to millions of patients who suffer from insomnia.”
The CloudSuite Industrial solution will enable Ebb Therapeutics to scale operations rapidly and meet the expanding customer and market demands with an exceptionally high level of quality. The Copley Consulting Group will provide installation, training, education, and implementation consulting to facilitate Ebb’s deployment of the fully-integrated enterprise solution.
“We are very excited about this partnership with Ebb Therapeutics,” said Robert Lane, CEO of Copley. “Through this collaboration, we’ll successfully implement a solution that will allow for a dynamic flow of information between Ebb and its customers and suppliers, and will facilitate Ebb’s delivery of the highest quality products and support to insomnia patients and their treating physicians.”